Market exclusion as agenda as court reviews firms' use of GPOs (group purchasing organisations)
This article was originally published in Clinica
A federal trial starting up next week in Texas could open a window on how large device companies use group purchasing organisations (GPOs) and other sales tactics to shut out small but promising competitors.
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.